Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and services, today introduced the 2008K@home, a hemodialysis system for use at the patient’s home, at the American Society of Nephrology’s Kidney Week 2011 meeting in Philadelphia, USA. The 2008K@home machine is built on the 2008® series hemodialysis machine platform that has delivered superior hemodialysis therapy for over 30 years.

This machine combines safety, efficacy and reliability with a simple user-interface that incorporates an on-screen tutorial to walk the user through set-up, treatment, and disconnection from therapy. Earlier this year, the U.S. Food and Drug Administration (FDA) cleared the 2008K@home machine for use.

Maureen Lyden-Green, Vice President for Home Therapies at Fresenius Medical Care North America said, With the growing interest in home therapies in the U.S., the 2008K@home machine provides another option for delivering hemodialysis to patients who want the freedom associated with being at home.

The 2008K@home provides patients with a smaller version of the in-center machine and allows flexibility to deliver a customized physician’s dialysis prescription for each patient, meeting the patient’s medical needs and suiting their lifestyle,” continued Chief Medical and Regulatory Affairs Officer Dr. Jose Diaz-Buxo